GenVec (GNVC) Says FDA Clinical Hold on CGF166 Phase 1/2 Lifted

July 25, 2016 7:30 AM
GenVec, Inc. (Nasdaq: GNVC) announced that it was notified by its collaborator, Novartis, that the Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Management Comments Trader Talk

Next Articles